BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27803799)

  • 1. Approach to patients with refractory coeliac disease.
    Nasr I; Nasr I; Campling H; Ciclitira PJ
    F1000Res; 2016; 5():. PubMed ID: 27803799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
    Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
    Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
    Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
    Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
    Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
    Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in refractory coeliac disease: a review.
    Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
    Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
    Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
    Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine and prednisone combination therapy in refractory coeliac disease.
    Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ
    Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell repertoires in refractory coeliac disease.
    Ritter J; Zimmermann K; Jöhrens K; Mende S; Seegebarth A; Siegmund B; Hennig S; Todorova K; Rosenwald A; Daum S; Hummel M; Schumann M
    Gut; 2018 Apr; 67(4):644-653. PubMed ID: 28188172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory coeliac disease.
    Daum S; Cellier C; Mulder CJ
    Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue.
    Daum S; Weiss D; Hummel M; Ullrich R; Heise W; Stein H; Riecken EO; Foss HD;
    Gut; 2001 Dec; 49(6):804-12. PubMed ID: 11709515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of refractory coeliac disease.
    Woodward J
    Ther Adv Chronic Dis; 2013 Mar; 4(2):77-90. PubMed ID: 23556127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges.
    Scarmozzino F; Pizzi M; Pelizzaro F; Angerilli V; Dei Tos AP; Piazza F; Savarino EV; Zingone F; Fassan M
    Front Oncol; 2023; 13():1273305. PubMed ID: 38023263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification and management of refractory coeliac disease.
    Rubio-Tapia A; Murray JA
    Gut; 2010 Apr; 59(4):547-57. PubMed ID: 20332526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel variant of EATL evolving from mucosal γδ-T-cells in a patient with type I RCD.
    van Wanrooij RL; de Jong D; Langerak AW; Ylstra B; van Essen HF; Heideman DA; Bontkes HJ; Mulder CJ; Bouma G
    BMJ Open Gastroenterol; 2015; 2(1):e000026. PubMed ID: 26462278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Jejunal ulcerations - a diagnostic challenge in a patient with coeliac disease].
    Weber M; Schumann M; Felber J; Mireskandari M; Schmidt C; Stallmach A
    Z Gastroenterol; 2015 Nov; 53(11):1261-6. PubMed ID: 26562400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
    Schmitz F; Tjon JM; van Bergen J; Koning F
    Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased circulating iNKT cell numbers in refractory coeliac disease.
    Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
    Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
    de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
    Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.